Trials / Conditions / Locally Advanced Breast Carcinoma

Locally Advanced Breast Carcinoma

15 registered clinical trials studyying Locally Advanced Breast Carcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T- NCT07137416	National Cancer Institute (NCI)	Phase 1
Recruiting	An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Posit NCT06999798	Mayo Clinic	Phase 1
Suspended	Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Ca NCT05547347	Mayo Clinic	—
Completed	Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer NCT05945290	Mayo Clinic	—
Recruiting	Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations NCT04550494	National Cancer Institute (NCI)	Phase 2
Withdrawn	Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520	Pamela Munster	Phase 1
Recruiting	SHAPE Neoadjuvant Chemotherapy Response NCT04715958	Kibo Nam	Phase 2 / Phase 3
Active Not Recruiting	INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study NCT04445844	Mridula George, MD	Phase 2
Withdrawn	Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer NCT04249167	Mayo Clinic	EARLY_Phase 1
Recruiting	Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inf NCT03941756	M.D. Anderson Cancer Center	N/A
Terminated	Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treatin NCT03101748	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positi NCT03281902	Mayo Clinic	—
Active Not Recruiting	Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Can NCT02115282	National Cancer Institute (NCI)	Phase 3
Active Not Recruiting	Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer NCT01463072	City of Hope Medical Center	Phase 2
Completed	Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer NCT01149083	National Cancer Institute (NCI)	Phase 2